LIPELLA PHARMS INC by Lipella Pharmaceuticals Inc. (LIPO) Stock Price Target 2026

The average analyst price target for LIPELLA PHARMS INC by Lipella Pharmaceuticals Inc. is $16, 3199900.0% above the current price. The one analyst covering it rates it Buy. The latest change came on Apr 9, 2024, when Maxim Group initiated coverage of LIPELLA PHARMS INC by Lipella Pharmaceuticals Inc. with a Buy rating and a $16 price target.

The Average Analyst Price Target for LIPELLA PHARMS INC by Lipella Pharmaceuticals Inc. is $16.

Price Target Range — 1 Quarters

Analyst Consensus — 1 Analysts

1Buy

Consensus RatingBuy# Analysts1Avg. Consensus PT$16Upside to Avg. PT+3199900.0%

Rating Trend — Last 9 Months

Latest Upgrades and Downgrades for LIPELLA PHARMS INC by Lipella Pharmaceuticals Inc. Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Apr 9, 2024	Maxim Group	Jason McCarthy	Initiate	Buy	$16

Analyst Ratings News

PRO
Maxim Group Initiates Coverage On Lipella Pharmaceuticals with Buy Rating, Announces Price Target of $2

Maxim Group analyst Jason McCarthy initiates coverage on Lipella Pharmaceuticals (NASDAQ:LIPO) with a Buy rating and announces Price Target of $2.

Benzinga Newsdesk